These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The regulatory role of natural killer cells in multiple sclerosis. Takahashi K; Aranami T; Endoh M; Miyake S; Yamamura T Brain; 2004 Sep; 127(Pt 9):1917-27. PubMed ID: 15229129 [TBL] [Abstract][Full Text] [Related]
3. [The natural cytotoxicity system in patients with multiple sclerosis: clinico-immunological parallels]. Cheknev SB; Latysheva OL; Demina TL; Sorokin AM; Gusev EI Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):16-9. PubMed ID: 2800805 [TBL] [Abstract][Full Text] [Related]
4. Natural killer cell activity in patients with multiple sclerosis given alpha interferon. Rice GP; Casali P; Merigan TC; Oldstone MB Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954 [TBL] [Abstract][Full Text] [Related]
5. [Role of immunoregulatory cells and natural killers in the pathogenesis of multiple sclerosis]. Tunkel' OI; Saidov MZ; Cheredeev AN; Koval'chuk LV; Skriabina EG Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):880-5. PubMed ID: 6224384 [TBL] [Abstract][Full Text] [Related]
6. Understanding the role of natural killer cell receptors and their human leukocyte antigen ligands in multiple sclerosis. Trachtenberg EA Ann Neurol; 2009 Jun; 65(6):626-8. PubMed ID: 19557875 [No Abstract] [Full Text] [Related]
7. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145 [TBL] [Abstract][Full Text] [Related]
8. [Regulation of the activity of human natural killer cells by autologous interferon]. Cheknev SB; Ershov FI; Pritsker AD; Latysheva OL Biull Eksp Biol Med; 1994 Sep; 118(9):281-4. PubMed ID: 7819561 [No Abstract] [Full Text] [Related]
10. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis. Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients. Rinaldi L; Gallo P; Calabrese M; Ranzato F; Luise D; Colavito D; Motta M; Guglielmo A; Del Giudice E; Romualdi C; Ragazzi E; D'Arrigo A; Dalle Carbonare M; Leontino B; Leon A Brain; 2006 Aug; 129(Pt 8):1993-2007. PubMed ID: 16870883 [TBL] [Abstract][Full Text] [Related]
12. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch. Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757 [TBL] [Abstract][Full Text] [Related]
20. Relationship between the immune system and the diseases of the central nervous system. Bokor M; Faragó A; Schnabel R; Garam T Ther Hung; 1992; 40(2):51-7. PubMed ID: 1462276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]